CCL3 is an important regulator to maintain CML cells by inhibiting normal hematopoiesis (Baba et al., 2013; Baba et al., 2016), and its expression was regulated by FGFR3 signaling (Masih-Khan et al., 2006). This evidence concerns the gene FGFR3 and chronic myelogenous leukemia, BCR-ABL1 positive.